August 27, 2024: Pain Management Collaboratory to Sponsor Fall Cyberseminar Series

Posted on by Sophia Ramirez

The Pain Management Collaboratory (PMC) will sponsor a series of presentations as part of the VA Spotlight on Pain Management (SoPM) Cyberseminar series, highlighting the accomplishments and future initiatives of the PMC. These webinars will feature early findings, lessons learned, and future directions for research based on the activities of PMC Pragmatic Clinical Trials.

The series will be held in monthly installments through the end of 2024:

  1. Tuesday, September 10, 11 am eastern: Scalable Mindfulness-Based Interventions for Chronic Pain: Results from the Learning to Apply Mindfulness to Pain (LAMP) Trial (Diana Burgess, PhD)
  2. Tuesday, October 1, 11 am eastern: Implementation of New Physical Therapy Programs for Knee Osteoarthritis in the VA (Kelli Allen, PhD)
  3. Tuesday, November 5, 11 am eastern: Optimizing Equity and Inclusion in Pragmatic Clinical Trials: Findings from the Pain Management Collaboratory (Travis Lovejoy, PhD)
  4. Tuesday, December 3, 11 am eastern: How Many Chiropractic Visits does it take to Help Veterans with Chronic Low Back Pain? Part 1: Characteristics of the VERDICT Sample (Cynthia Long, PhD, PStat; Christine Goertz, DC, PhD)

Registration is required for participation, but there is no cost. Continuing education credits are available for several disciplines for participants who are affiliated with VA.

For more information visit the Cyberseminar Series Description page.

 

About the PMC

The PMC is an important tri-government agency partnership involving the National Institutes of Health and Departments of Defense and Veterans Affairs that supports a growing number of large-scale, multisite, pragmatic clinical trials (PCTs) of nonpharmacological approaches for the management of pain and common co-occurring conditions in military and Veteran health systems. Launched in 2017, the originally supported 11 PCTs are nearing completion and are ready to present early findings, lessons learned in the conduct of the trials, and future directions and opportunities for implementation of important findings and products and for future research.